Compounds > 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane
Page last updated: 2024-09-03

1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane and strychnine

1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane has been researched along with strychnine in 1 studies

Compound Research Comparison

Studies
(1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane)		Trials
(1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane)		Recent Studies (post-2010)
(1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane)		Studies
(strychnine)		Trials
(strychnine)		Recent Studies (post-2010) (strychnine)
40054,77816490

Protein Interaction Comparison

ProteinTaxonomy1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane (IC50)strychnine (IC50)
Glycine receptor subunit alpha-1Homo sapiens (human)0.1843
Glycine receptor subunit betaHomo sapiens (human)0.2871

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casida, JE; Kamijima, M1

Other Studies

1 other study(ies) available for 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane and strychnine

ArticleYear
Regional modification of [(3)H]Ethynylbicycloorthobenzoate binding in mouse brain GABA(A) receptor by endosulfan, fipronil, and avermectin B(1a).
    Toxicology and applied pharmacology, 2000, Mar-01, Volume: 163, Issue:2

    Topics: Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Endosulfan; Ivermectin; Mice; Molecular Structure; Pyrazoles; Receptors, GABA-A; Strychnine; Tritium

2000